These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19625706)

  • 1. Nicked {beta}2-glycoprotein I binds angiostatin 4.5 (plasminogen kringle 1-5) and attenuates its antiangiogenic property.
    Nakagawa H; Yasuda S; Matsuura E; Kobayashi K; Ieko M; Kataoka H; Horita T; Atsumi T; Koike T
    Blood; 2009 Sep; 114(12):2553-9. PubMed ID: 19625706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential binding of plasminogen, plasmin, and angiostatin4.5 to cell surface beta-actin: implications for cancer-mediated angiogenesis.
    Wang H; Doll JA; Jiang K; Cundiff DL; Czarnecki JS; Wilson M; Ridge KM; Soff GA
    Cancer Res; 2006 Jul; 66(14):7211-5. PubMed ID: 16849568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmin can reduce the function of human beta2 glycoprotein I by cleaving domain V into a nicked form.
    Ohkura N; Hagihara Y; Yoshimura T; Goto Y; Kato H
    Blood; 1998 Jun; 91(11):4173-9. PubMed ID: 9596664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Function of β2-glycoprotein I in Angiogenesis and Its in Vivo Distribution in Tumor Xenografts.
    Wahyuningsih AT; Shen L; Kobayashi K; Sasaki T; Takenaka F; Hanada T; Akehi M; Akahoshi A; Ozeki E; Ando E; Matsuura E
    Acta Med Okayama; 2016; 70(1):13-24. PubMed ID: 26899605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta2-glycoprotein I, anti-beta2-glycoprotein I, and fibrinolysis.
    Yasuda S; Atsumi T; Ieko M; Koike T
    Thromb Res; 2004; 114(5-6):461-5. PubMed ID: 15507279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different inhibitors of plasmin differentially affect angiostatin production and angiogenesis.
    Hatziapostolou M; Katsoris P; Papadimitriou E
    Eur J Pharmacol; 2003 Jan; 460(1):1-8. PubMed ID: 12535853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell surface-dependent generation of angiostatin4.5.
    Wang H; Schultz R; Hong J; Cundiff DL; Jiang K; Soff GA
    Cancer Res; 2004 Jan; 64(1):162-8. PubMed ID: 14729620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicked beta2-glycoprotein I: a marker of cerebral infarct and a novel role in the negative feedback pathway of extrinsic fibrinolysis.
    Yasuda S; Atsumi T; Ieko M; Matsuura E; Kobayashi K; Inagaki J; Kato H; Tanaka H; Yamakado M; Akino M; Saitou H; Amasaki Y; Jodo S; Amengual O; Koike T
    Blood; 2004 May; 103(10):3766-72. PubMed ID: 14726399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation.
    Stack MS; Gately S; Bafetti LM; Enghild JJ; Soff GA
    Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):77-84. PubMed ID: 10229661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase-19 inhibits growth of endothelial cells by generating angiostatin-like fragments from plasminogen.
    Brauer R; Beck IM; Roderfeld M; Roeb E; Sedlacek R
    BMC Biochem; 2011 Jul; 12():38. PubMed ID: 21787393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo induction of antiangiogenic activity by plasminogen activators and captopril.
    Merchan JR; Chan B; Kale S; Schnipper LE; Sukhatme VP
    J Natl Cancer Inst; 2003 Mar; 95(5):388-99. PubMed ID: 12618504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein(a) inhibits in vitro tube formation in endothelial cells: identification of roles for Kringle V and the plasminogen activation system.
    Liu L; Boffa MB; Koschinsky ML
    PLoS One; 2013; 8(1):e52287. PubMed ID: 23326327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiostatin antagonizes the action of VEGF-A in human endothelial cells via two distinct pathways.
    Chen YH; Wu HL; Chen CK; Huang YH; Yang BC; Wu LW
    Biochem Biophys Res Commun; 2003 Oct; 310(3):804-10. PubMed ID: 14550275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmin-induced migration of endothelial cells. A potential target for the anti-angiogenic action of angiostatin.
    Tarui T; Majumdar M; Miles LA; Ruf W; Takada Y
    J Biol Chem; 2002 Sep; 277(37):33564-70. PubMed ID: 12087108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiostatin and plasminogen share binding to endothelial cell surface actin.
    Dudani AK; Ben-Tchavtchavadze M; Porter S; Tackaberry E
    Biochem Cell Biol; 2005 Feb; 83(1):28-35. PubMed ID: 15746964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiangiogenic kringles derived from human plasminogen and apolipoprotein(a) inhibit fibrinolysis through a mechanism that requires a functional lysine-binding site.
    Ahn JH; Lee HJ; Lee EK; Yu HK; Lee TH; Yoon Y; Kim SJ; Kim JS
    Biol Chem; 2011 Apr; 392(4):347-56. PubMed ID: 21194375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiostatin formation involves disulfide bond reduction and proteolysis in kringle 5 of plasmin.
    Stathakis P; Lay AJ; Fitzgerald M; Schlieker C; Matthias LJ; Hogg PJ
    J Biol Chem; 1999 Mar; 274(13):8910-6. PubMed ID: 10085135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis.
    Ji WR; Castellino FJ; Chang Y; Deford ME; Gray H; Villarreal X; Kondri ME; Marti DN; Llinás M; Schaller J; Kramer RA; Trail PA
    FASEB J; 1998 Dec; 12(15):1731-8. PubMed ID: 9837863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells.
    Cao Y; Ji RW; Davidson D; Schaller J; Marti D; Söhndel S; McCance SG; O'Reilly MS; Llinás M; Folkman J
    J Biol Chem; 1996 Nov; 271(46):29461-7. PubMed ID: 8910613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiostatin binds to tyrosine kinase substrate annexin II through the lysine-binding domain in endothelial cells.
    Tuszynski GP; Sharma MR; Rothman VL; Sharma MC
    Microvasc Res; 2002 Nov; 64(3):448-62. PubMed ID: 12453439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.